Compare CMI & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMI | NTRA |
|---|---|---|
| Founded | 1919 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.7B | 56.7B |
| IPO Year | 1994 | 2015 |
| Metric | CMI | NTRA |
|---|---|---|
| Price | $434.10 | $287.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 22 |
| Target Price | ★ $624.90 | $410.26 |
| AVG Volume (30 Days) | 1.3M | ★ 1.9M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.03% | N/A |
| EPS Growth | N/A | ★ 0.65 |
| EPS | ★ 19.70 | N/A |
| Revenue | ★ $33,670,000,000.00 | $210,939,000.00 |
| Revenue This Year | $10.25 | $30.65 |
| Revenue Next Year | $9.35 | $21.31 |
| P/E Ratio | $21.97 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $431.30 | $181.00 |
| 52 Week High | $737.76 | $437.41 |
| Indicator | CMI | NTRA |
|---|---|---|
| Relative Strength Index (RSI) | 26.85 | 26.33 |
| Support Level | N/A | $189.54 |
| Resistance Level | $544.45 | $288.04 |
| Average True Range (ATR) | 15.27 | 21.43 |
| MACD | -4.40 | -10.31 |
| Stochastic Oscillator | 1.83 | 5.81 |
Cummins is a leading manufacturer of diesel and other engines used in heavy- and medium-duty commercial trucks, off-highway equipment, and locomotives, in addition to prime power and standby generators. The company also sells powertrain components, which include filtration products, transmissions, turbochargers, aftertreatment systems, and fuel systems. Sales are approximately 60% US and Canada and 40% rest of the world. Much of Cummins' foreign sales (China, India, and so forth) are through joint ventures. The company operates 650 distributors and over 19,000 dealer locations across 190 countries. Cummins' business model is unique as it competes with many of its heavy-duty truck manufacturer customers, which also make their own engines.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.